Brenda McKinstry
Nurse Practitioner · Massillon, OHNPI 1225076631
Payments from drug & device makers
Across 37 payments — averaging $20.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$210
- Teva Pharmaceuticals USA, Inc.$209
- Lundbeck LLC$62
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$55
- Johnson & Johnson$40
- AbbVie$35
- plus $136 from 5 others
What the payments were for
- Food & beverage$747100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 9 | $210 |
| Teva Pharmaceuticals USA, Inc. | 10 | $209 |
| Lundbeck LLC | 3 | $62 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $55 |
| Johnson & Johnson | 2 | $40 |
| AbbVie | 2 | $35 |
| Noven Therapeutics, LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Corium, LLC | 1 | $21 |
| Alkermes, Inc. | 1 | $19 |
How this compares
$747 in reported general payments places this provider in the 80th percentile of 4,700 nurse practitioner providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Olanzapine | 22 | $1,122 |
| Haloperidol Decanoate | 12 | $639 |
| Quetiapine Fumarate | 37 | $498 |
| Aripiprazole | 12 | $387 |
| Risperidone | 20 | $333 |
| Divalproex Sodium | 11 | $243 |
| Benztropine Mesylate | 20 | $202 |
| Buspirone Hcl | 11 | $143 |
| Prazosin Hcl | 13 | $113 |
| Trazodone Hcl | 21 | $104 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Massillon
- Margaret BobonichCleveland$235K
- Mary GallagherWestlake$229K
- Sonia HissettCincinnati$179K
- Ashley TaylorNew Albany$107K
- Beth FaimanCleveland$101K
- Katherine AlexanderColumbus$99K
- Tiffany JonesCincinnati$99K
- Kate NewmanWestlake$78K
- Daniella GerySouth Euclid$73K
- Amy HazelCanton$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.